"Without careful consideration of the impact of these changes, we risk long-term damage" to medical research, writes Dr. George Weiner.

Shares of Tempus AI rose by 13.36 percent on Thursday to close at $83.75 apiece as investors cheered the company’s partnership with the nonprofit organization Institute for Follicular Lymphoma ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.